Track 3: Oncology Product Research and Review for Postdoctoral Research Fellows

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

This fellowship will train individuals in the aspects of research and review of medical product development process to facilitate the movement of drugs, biologics, and devices from the bench to the bedside.

Fellows will receive formal training and mentoring in the relevant federal statutes, regulations, principles, and practices of FDA medical product review, including issues related to product development, e.g., manufacturing processes, production, purification, characterization, testing, quality control, and quality assurance, understanding the biology, chemistry, pharmacoepidemiology, manufacturing, postmarketing surveillance, and mechanism of action/pathogenesis of disease.

Training Goals and Outcomes

  • Understanding of cancer biology relevant to molecular targeted therapy
  • Understanding of regulatory requirements for product development and approval process and participation in the review of regulatory files (e.g. IND, NDA, BLA, 510k, PMA) for chemistry, manufacturing control, pharmacology/toxicology and clinical trial design
  • Participation in the development of product standards and guidance document development
  • Understanding of critical ethical issues and requirements in product research, development, and review, including protection of human research subjects and conflict of interest
  • Understanding the manufacturing processes, e.g., production, purification, characterization, testing, quality control, and quality assurance
  • Participation in and understanding of product-related research, i.e. understanding the biology, chemistry, pharmacoepidemiology, manufacturing, post-marketing surveillance, and mechanism of action/pathogenesi

Eligibility Requirements

  • Ph.D., M.D., or M.D./Ph.D.
  • Minimum of 3 years of postdoctoral training
  • Must be within 5 years of the applicants most advanced degree
  • U.S. citizenship or permanent residency
  • Experience and interest in molecular targets or product development and/or design
  • Fellows finishing their fourth or fifth year may qualify for a sixth year CRTA extension

Curricula and Responsibilities

The program time frame will be for up to two years and include up to six fellows per year.

First Year

Fellows will choose one of the product or clinical divisions in FDA Centers for supplemental training. In a particular product division, these fellows will be matched to a pre-screened pool of principal investigators or to a branch chief for regulatory research and regulatory experience. Fellows with a Ph.D. degree will be matched to a product division or pharmacology/toxicology branch in a clinical division.

Fellows will have the option to perform translational research in the participating division or office. These fellows will undertake and participate in various training activities of the chosen division. The division director or their designee will oversee these activities.

Fellows will spend approximately 40% of their time in training to become proficient in the process of product or pharmacology/toxicology reviews; and policy and guidance document development. Fellows will also participate in branch, lab, division and office meetings, grand rounds, and regulatory presentations offered at the participating Center. They will also participate in regulatory meetings with investigators and sponsors.

Fellows are expected to conduct research activities under the guidance of principal investigators in ongoing projects in the lab. These fellows will have option to choose their principal investigator at the beginning of program.

During the training program, fellows will be expected to attend and take and pass required tests in reviewer training and various courses offered by participating FDA Centers.

Second Year

The first-year curricula and activities may be continued in the second year of the program based on the fellow's performance evaluated by PI, branch chief, division director and associate directors of research at both institutions.

How to Apply

Applications are due May 31, 2017 for an earliest start date of October 1, 2017.

Please submit:

  • Curriculum Vitae
  • Personal statement of research goals
  • Three letters of reference

For more detailed information and application guidelines view the NCI-FDA Research and Regulatory Review Fellowships Guidelines for Application(PDF)

Send application materials to:
Jonathan S. Wiest, Ph.D.
Director, Center for Cancer Training, NCI
9609 Medical Center Dr.
Rm. 2W104, MSC 9707
Bethesda, MD 20892-9707
Office Phone: 240-276-5628
Email: Wiestj@mail.nih.gov

Mentors

While at FDA, fellows will each be assigned a mentor who will be a senior member of FDA scientific review staff.

Review list of mentors and projects here.

Most text on the National Cancer Institute website may be reproduced or reused freely. The National Cancer Institute should be credited as the source and a link to this page included, e.g., “Track 3: Oncology Product Research and Review for Postdoctoral Research Fellows was originally published by the National Cancer Institute.”

Please note that blog posts that are written by individuals from outside the government may be owned by the writer, and graphics may be owned by their creator. In such cases, it is necessary to contact the writer, artists, or publisher to obtain permission for reuse.

We welcome your comments on this post. All comments must follow our comment policy.